Trial intelligence / Profile preview

Volatile vs TIVA in Brain Tumor Craniotomy

NCT06779890Phase 4Recruiting

Start
May 2025
Primary completion
Sep 2026
Modality
Allosteric Modulators
Countries
1
01

Overview

A Phase 4 trial of sevoflurane, desflurane in brain tumor. Started May 2025; status: recruiting.

02

Drugs

sevofluranedesflurane
03

Conditions

brain tumor

Beyond the preview

Go deeper on NCT06779890.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06779890.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call